Bioplastics And Biopolymers Market Scope And Analysis

  • Report Code : TIPRE00005472
  • Category : Chemicals and Materials
  • Status : Published
  • No. of Pages : 232
Buy Now

Bioplastics and Biopolymers Market Scope and Analysis by 2030

Buy Now


Bioplastics and Biopolymers Market Report Scope

Report Attribute Details
Market size in 2022 US$ 6.7 Billion
Market Size by 2030 US$ 14.64 Billion
Global CAGR (2022 - 2030) 10.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product Type
  • Polyethylene
  • Polyethylene Terephthalate
  • Polylactic Acid
  • Polytrimethylene Terephthalate
  • Polybutylene Adipate Terephthalate
  • Polybutylene Succinate
  • Cellulose
  • Blends
By End Use Industry
  • Packaging
  • Consumer Goods
  • Automotive
  • Textile
  • Building and Construction
  • Medical
  • Agriculture
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Arkema SA
  • BASF SE
  • Mitsui Chemicals Inc
  • Cardia Bioplastics Australia Pty Ltd
  • Braskem SA
  • Saudi Basic Industries Corp
  • Mitsubishi Chemical Holdings Corp
  • Corbion NV
  • Novamont SpA
  • IMPACT OF COVID/IMPACT OF GEOPOLITICAL SCENARIO/IMPACT OF RECESSION

    Lockdowns, travel restrictions, and business shutdowns due to the COVID-19 pandemic adversely affected economies and industries in various countries of North America, Europe, Asia Pacific (APAC), South & Central America, and the Middle East & Africa (MEA). The crisis disturbed global supply chains, manufacturing activities, delivery schedules, and essential and nonessential product sales. Various companies announced possible delays in product deliveries and a slump in future sales of their products in 2020. Further, the international travel bans imposed by various governments in Europe, Asia Pacific, and North America forced several companies to discontinue their collaboration and partnership plans. All these factors hampered the chemicals & materials industry in 2020 and early 2021, thereby restraining the growth of various markets related to this industry, including the bioplastics and biopolymers market.

    Before the COVID-19 outbreak, the bioplastics and biopolymers market was mainly driven by the rising demand from packaging, consumer goods, automotive, and building & construction industries. However, in 2020, various industries had to slow down their operations due to disruptions in value chains caused by the shutdown of national and international boundaries. The COVID-19 pandemic disrupted the supply chain of key raw materials and disturbed manufacturing processes due to restrictions imposed by government authorities in various countries. However, the economies revived their operations. The previously postponed manufacturing projects were resumed, further providing an opportunity for the biocomposite market players to regain normalcy.

    COMPETITIVE LANDSCAPE AND KEY COMPANIES

    Arkema SA, BASF SE, Mitsui Chemicals Inc, Cardia Bioplastics Australia Pty Ltd, Braskem SA, Saudi Basic Industries Corp, Corbion NV, Mitsubishi Chemical Holdings Corp, Novamont SpA, and Eastman Chemical Co. are among the key players operating in the bioplastics and biopolymers market.